Cargando…

Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer

BACKGROUND: The Myc oncogene family has been implicated in many human malignancies and is often associated with particularly aggressive disease, suggesting Myc as an attractive prognostic marker and therapeutic target. However, for epithelial ovarian cancer (EOC), there is little consensus on the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, MoonSun, Russell, Amanda J, Kennedy, Catherine, Gifford, Andrew J, Mallitt, Kylie-Ann, Sivarajasingam, Siva, Bowtell, David D, DeFazio, Anna, Haber, Michelle, Norris, Murray D, Henderson, Michelle J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649713/ https://www.ncbi.nlm.nih.gov/pubmed/31360864 http://dx.doi.org/10.1093/jncics/pky047

Ejemplares similares

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
por: Gao, Bo, et al.
Publicado: (2014)

Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian Cancer
por: Gao, Jixuan, et al.
Publicado: (2022)

ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma
por: Huynh, Tony, et al.
Publicado: (2012)

Oncogenic MYC amplifies mitotic perturbations
por: Littler, Samantha, et al.
Publicado: (2019)

Myc, Oncogenic Protein Translation, and the Role of Polyamines
por: Flynn, Andrea T., et al.
Publicado: (2018)

Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling
por: Dorstyn, Loretta, et al.
Publicado: (2019)

Detection of the c-myc oncogene product in testicular cancer.
por: Sikora, K., et al.
Publicado: (1985)

High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
por: Baumbusch, Lars O., et al.
Publicado: (2013)

Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4‐MYC oncogenic axis in multiple myeloma
por: Agnarelli, Alessandro, et al.
Publicado: (2022)

Detection of the c-myc oncogene product in colonic polyps and carcinomas.
por: Stewart, J., et al.
Publicado: (1986)

Coamplification of the L‐myc and N‐myc Oncogenes in a Neuroblastoma Cell Line
por: Jinbo, Takeshi, et al.
Publicado: (1989)

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)

Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
por: Smith, D. R., et al.
Publicado: (1993)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene
por: Demma, Mark J., et al.
Publicado: (2019)

Annotating MYC oncogene status with (89)Zr-transferrin imaging
por: Holland, Jason P., et al.
Publicado: (2012)

High Intrinsic Oncogenic Potential in the Myc-Box-Deficient Hydra Myc3 Protein
por: Lechable, Marion, et al.
Publicado: (2023)

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
por: Eertink, J. J., et al.
Publicado: (2021)

Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer
por: Watters, A D, et al.
Publicado: (2002)

SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein Stability
por: Marshall, Glenn M., et al.
Publicado: (2011)

RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
por: Selvarajan, V, et al.
Publicado: (2017)

A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
por: Jones, D. J., et al.
Publicado: (1987)

Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
por: Crossen, P. E., et al.
Publicado: (1994)

Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
por: Barna, Maria, et al.
Publicado: (2008)

Targeting oncogenic Myc as a strategy for cancer treatment
por: Chen, Hui, et al.
Publicado: (2018)

AMPLIFIED ALLELE OF THE HUMAN N‐myc ONCOGENE IN NEUROBLASTOMAS
por: Yamada, Masao, et al.
Publicado: (1988)

MYC Oncogene Contributions to Release of Cell Cycle Brakes
por: García-Gutiérrez, Lucía, et al.
Publicado: (2019)

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018)

Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1
por: Shahbazi, Jeyran, et al.
Publicado: (2014)

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
por: Raffeiner, Philipp, et al.
Publicado: (2014)

Gay Men’s Use of Condoms With Casual Partners Depends on the Extent of Their Prior Acquaintance
por: Rouwenhorst, Evelien, et al.
Publicado: (2011)

Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study
por: Hung, J, et al.
Publicado: (2012)

The MYC 3′ Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells
por: Rennoll, Sherri A., et al.
Publicado: (2016)

Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
por: Kurisetty, Vittal, et al.
Publicado: (2013)

Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc
por: D'Artista, Luana, et al.
Publicado: (2016)

Regulation of cancer cell metabolism: oncogenic MYC in the driver’s seat
por: Dong, Yang, et al.
Publicado: (2020)

High resolution melting for mutation scanning of TP53 exons 5–8
por: Krypuy, Michael, et al.
Publicado: (2007)

Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
por: Terrier, P., et al.
Publicado: (1988)

Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms
por: Chan, Gary KL, et al.
Publicado: (2023)

Oncogenic structural aberration landscape in gastric cancer genomes
por: Saito-Adachi, Mihoko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iqeesbsqb55jou909feluupf0c